Interrogating Mutant Allele Expression via Customized Reference Genomes to Define Influential Cancer Mutations.

Area of Science:

• Genomics
• Cancer Biology
• Bioinformatics

Background:

• Genetic alterations are fundamental to cancer development and progression.
• Distinguishing driver mutations from neutral mutations is a significant challenge in cancer biology.

Purpose of the Study:

• To develop a method for categorizing mutations based on their allelic expression.
• To assess the impact of mutant allele expression on cancer driver mutation detection and patient stratification.

Main Methods:

• Development of MAXX (Mutation Allelic Expression Extractor) software.
• Utilized RNA-sequencing data to delineate allelic expression of single nucleotide variants and small insertions/deletions.
• Categorized mutations into three groups based on mutant allele expression patterns.

Main Results:

• MAXX effectively delineates allelic expression, categorizing mutations by mutant allele expression, biallelic expression loss, or wild-type allele expression.
• Incorporating allelic expression patterns enhanced the sensitivity of driver mutation detection methods in pancreatic ductal adenocarcinoma (PDAC).
• Identified PDAC subtypes with prognostic significance and potential therapeutic implications based on allelic expression.

Conclusions:

• Differentiating mutations by their mutant allele expression using MAXX aids in parsing somatic variants.
• This approach helps elucidate a gene's specific role in cancer.
• Allelic expression analysis offers a valuable tool for cancer genomics and precision medicine.